{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:40:35Z","timestamp":1789044035294,"version":"build-2803163510"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM120156-01A1"],"award-info":[{"award-number":["R01GM120156-01A1"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002529"],"award-info":[{"award-number":["UL1TR002529"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Indiana Drug Discovery Alliance","award":["2286233"],"award-info":[{"award-number":["2286233"]}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY025641"],"award-info":[{"award-number":["R01EY025641"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cohen Endowment for Macular Degeneration Research"},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["Challenge Grant"],"award-info":[{"award-number":["Challenge Grant"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Ocular neovascular diseases including neovascular age-related macular degeneration (nvAMD) are widespread causes of blindness. Patients\u2019 non-responsiveness to currently used biologics that target vascular endothelial growth factor (VEGF) poses an unmet need for novel therapies. Here, we identify protein arginine methyltransferase 5 (PRMT5) as a novel therapeutic target for nvAMD. PRMT5 is a well-known epigenetic enzyme. We previously showed that PRMT5 methylates and activates a proangiogenic and proinflammatory transcription factor, the nuclear factor kappa B (NF-\u03baB), which has a master role in tumor progression, notably in pancreatic ductal adenocarcinoma and colorectal cancer. We identified a potent and specific small molecule inhibitor of PRMT5, PR5-LL-CM01, that dampens the methylation and activation of NF-\u03baB. Here for the first time, we assessed the antiangiogenic activity of PR5-LL-CM01 in ocular cells. Immunostaining of human nvAMD sections revealed that PRMT5 is highly expressed in the retinal pigment epithelium (RPE)\/choroid where neovascularization occurs, while mouse eyes with laser induced choroidal neovascularization (L-CNV) showed PRMT5 is overexpressed in the retinal ganglion cell layer and in the RPE\/choroid. Importantly, inhibition of PRMT5 by PR5-LL-CM01 or shRNA knockdown of PRMT5 in human retinal endothelial cells (HRECs) and induced pluripotent stem cell (iPSC)-derived choroidal endothelial cells (iCEC2) reduced NF-\u03baB activity and the expression of its target genes, such as tumor necrosis factor \u03b1 (TNF-\u03b1) and VEGF-A. In addition to inhibiting angiogenic properties of proliferation and tube formation, PR5-LL-CM01 blocked cell cycle progression at G\n                    <jats:sub>1<\/jats:sub>\n                    \/S-phase in a dose-dependent manner in these cells. Thus, we provide the first evidence that inhibition of PRMT5 impedes angiogenesis in ocular endothelial cells, suggesting PRMT5 as a potential therapeutic target to ameliorate ocular neovascularization.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-28215-w","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T06:03:32Z","timestamp":1675145012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["PRMT5 is a therapeutic target in choroidal neovascularization"],"prefix":"10.1038","volume":"13","author":[{"given":"Anbukkarasi","family":"Muniyandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamakshi","family":"Sishtla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishat","family":"Motolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan R.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Boulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Corson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"28215_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-66014-7_1","volume":"1256","author":"TDL Keenan","year":"2021","unstructured":"Keenan, T. D. L., Cukras, C. A. & Chew, E. Y. Age-related macular degeneration: Epidemiology and clinical aspects. Adv. Exp. Med. Biol. 1256, 1\u201331. https:\/\/doi.org\/10.1007\/978-3-030-66014-7_1 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"28215_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/07853890.2010.532150","volume":"44","author":"K Kinnunen","year":"2012","unstructured":"Kinnunen, K. & Yl\u00e4-Herttuala, S. Vascular endothelial growth factors in retinal and choroidal neovascular diseases. Ann. Med. 44, 1\u201317. https:\/\/doi.org\/10.3109\/07853890.2010.532150 (2012).","journal-title":"Ann. Med."},{"key":"28215_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","volume":"49","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro, P. A. Molecular pathogenesis of retinal and choroidal vascular diseases. Prog. Retin. Eye Res. 49, 67\u201381. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.06.002 (2015).","journal-title":"Prog. Retin. Eye Res."},{"key":"28215_CR4","doi-asserted-by":"publisher","first-page":"29619","DOI":"10.1038\/srep29619","volume":"6","author":"N Nagai","year":"2016","unstructured":"Nagai, N. et al. Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: Implications of serous pigment epithelial detachment. Sci. Rep. 6, 29619\u201329619. https:\/\/doi.org\/10.1038\/srep29619 (2016).","journal-title":"Sci. Rep."},{"key":"28215_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/B978-0-12-820472-6.00064-5","volume-title":"Comprehensive Pharmacology","author":"A Motolani","year":"2022","unstructured":"Motolani, A., Martin, M., Sun, M. & Lu, T. NF-\u03baB and cancer therapy drugs. In Comprehensive Pharmacology (ed. Kenakin, T.) 351\u2013363 (Elsevier, 2022)."},{"key":"28215_CR6","doi-asserted-by":"publisher","first-page":"15934","DOI":"10.1038\/s41598-020-72942-3","volume":"10","author":"A-V Hartley","year":"2020","unstructured":"Hartley, A.-V. et al. PRMT5-mediated methylation of YBX1 regulates NF-\u03baB activity in colorectal cancer. Sci. Rep. 10, 15934. https:\/\/doi.org\/10.1038\/s41598-020-72942-3 (2020).","journal-title":"Sci. Rep."},{"key":"28215_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147429","author":"M Martin","year":"2021","unstructured":"Martin, M., Sun, M., Motolani, A. & Lu, T. The pivotal player: Components of NF-\u03baB pathway as promising biomarkers in colorectal cancer. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22147429 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"28215_CR8","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu, T., Zhang, L., Joo, D. & Sun, S.-C. NF-\u03baB signaling in inflammation. Signal Transduct. Target. Ther. 2, 17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23 (2017).","journal-title":"Signal Transduct. Target. Ther."},{"key":"28215_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2010.177","volume":"21","author":"S-C Sun","year":"2011","unstructured":"Sun, S.-C. Non-canonical NF-\u03baB signaling pathway. Cell Res. 21, 71\u201385. https:\/\/doi.org\/10.1038\/cr.2010.177 (2011).","journal-title":"Cell Res."},{"key":"28215_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2174\/1566524013363816","volume":"1","author":"Y Yamamoto","year":"2001","unstructured":"Yamamoto, Y. & Gaynor, R. B. Role of the NF-\u03baB pathway in the pathogenesis of human disease states. Curr. Mol. Med. 1, 287\u2013296. https:\/\/doi.org\/10.2174\/1566524013363816 (2001).","journal-title":"Curr. Mol. Med."},{"key":"28215_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jtos.2012.04.001","volume":"10","author":"W Lan","year":"2012","unstructured":"Lan, W., Petznick, A., Heryati, S., Rifada, M. & Tong, L. Nuclear factor-\u03baB: Central regulator in ocular surface inflammation and diseases. Ocul. Surf. 10, 137\u2013148. https:\/\/doi.org\/10.1016\/j.jtos.2012.04.001 (2012).","journal-title":"Ocul. Surf."},{"key":"28215_CR12","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1073\/pnas.93.7.2832","volume":"93","author":"RA Stoltz","year":"1996","unstructured":"Stoltz, R. A., Abraham, N. G. & Laniado-Schwartzman, M. The role of NF-\u03baB in the angiogenic response of coronary microvessel endothelial cells. Proc. Natl. Acad. Sci. USA. 93, 2832\u20132837. https:\/\/doi.org\/10.1073\/pnas.93.7.2832 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"28215_CR13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3892\/or_00000690","volume":"23","author":"T-X Xie","year":"2010","unstructured":"Xie, T.-X., Xia, Z., Zhang, N., Gong, W. & Huang, S. Constitutive NF-\u03baB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. Oncol. Rep. 23, 725\u2013732. https:\/\/doi.org\/10.3892\/or_00000690 (2010).","journal-title":"Oncol. Rep."},{"key":"28215_CR14","first-page":"1891","volume":"40","author":"H Oh","year":"1999","unstructured":"Oh, H. et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Investig. Ophthalmol. Vis. Sci. 40, 1891\u20131898 (1999).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"28215_CR15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/archopht.122.7.1013","volume":"122","author":"SW Cousins","year":"2004","unstructured":"Cousins, S. W., Espinosa-Heidmann, D. G. & Csaky, K. G. Monocyte activation in patients with age-related macular degeneration: A biomarker of risk for choroidal neovascularization?. Arch. Ophthalmol. 122, 1013\u20131018. https:\/\/doi.org\/10.1001\/archopht.122.7.1013 (2004).","journal-title":"Arch. Ophthalmol."},{"key":"28215_CR16","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.exer.2006.07.007","volume":"83","author":"X Shi","year":"2006","unstructured":"Shi, X. et al. Inhibition of TNF-\u03b1 reduces laser-induced choroidal neovascularization. Exp. Eye Res. 83, 1325\u20131334. https:\/\/doi.org\/10.1016\/j.exer.2006.07.007 (2006).","journal-title":"Exp. Eye Res."},{"key":"28215_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.exer.2014.07.003","volume":"127","author":"RT Liu","year":"2014","unstructured":"Liu, R. T. et al. Vinpocetine inhibits amyloid-beta induced activation of NF-\u03baB, NLRP3 inflammasome and cytokine production in retinal pigment epithelial cells. Exp. Eye Res. 127, 49\u201358. https:\/\/doi.org\/10.1016\/j.exer.2014.07.003 (2014).","journal-title":"Exp. Eye Res."},{"key":"28215_CR18","doi-asserted-by":"publisher","first-page":"e87530","DOI":"10.1371\/journal.pone.0087530","volume":"9","author":"H Lu","year":"2014","unstructured":"Lu, H. et al. IKK2 inhibition attenuates laser-induced choroidal neovascularization. PLoS ONE 9, e87530. https:\/\/doi.org\/10.1371\/journal.pone.0087530 (2014).","journal-title":"PLoS ONE"},{"key":"28215_CR19","first-page":"116","volume":"22","author":"H Wang","year":"2016","unstructured":"Wang, H., Han, X., Wittchen, E. S. & Hartnett, M. E. TNF-\u03b1 mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent \u03b2-catenin activation. Mol. Vis. 22, 116\u2013128 (2016).","journal-title":"Mol. Vis."},{"key":"28215_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/path.4870","volume":"241","author":"S Ghosh","year":"2017","unstructured":"Ghosh, S. et al. Activating the AKT2-nuclear factor-\u03baB-lipocalin-2 axis elicits an inflammatory response in age-related macular degeneration. J. Pathol. 241, 583\u2013588. https:\/\/doi.org\/10.1002\/path.4870 (2017).","journal-title":"J. Pathol."},{"key":"28215_CR21","doi-asserted-by":"publisher","first-page":"9672","DOI":"10.1038\/s41598-017-10124-4","volume":"7","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. TGF-\u03b2 participates choroid neovascularization through Smad2\/3-VEGF\/TNF-\u03b1 signaling in mice with laser-induced wet age-related macular degeneration. Sci. Rep. 7, 9672\u20139672. https:\/\/doi.org\/10.1038\/s41598-017-10124-4 (2017).","journal-title":"Sci. Rep."},{"key":"28215_CR22","doi-asserted-by":"publisher","first-page":"112581","DOI":"10.1016\/j.yexcr.2021.112581","volume":"403","author":"F Hikage","year":"2021","unstructured":"Hikage, F. et al. NF-\u03baB activation in retinal microglia is involved in the inflammatory and neovascularization signaling in laser-induced choroidal neovascularization in mice. Exp. Cell Res. 403, 112581. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112581 (2021).","journal-title":"Exp. Cell Res."},{"key":"28215_CR23","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.1038\/s41467-021-27488-x","volume":"12","author":"R Sharma","year":"2021","unstructured":"Sharma, R. et al. Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model. Nat. Commun. 12, 7293. https:\/\/doi.org\/10.1038\/s41467-021-27488-x (2021).","journal-title":"Nat. Commun."},{"key":"28215_CR24","doi-asserted-by":"publisher","first-page":"e0251931","DOI":"10.1371\/journal.pone.0251931","volume":"16","author":"Y Xin","year":"2021","unstructured":"Xin, Y., Zefeng, K., Ling, L. & Ruijuan, G. Association between NF-\u03baB polymorphism and age-related macular degeneration in a high-altitude population. PLoS ONE 16, e0251931. https:\/\/doi.org\/10.1371\/journal.pone.0251931 (2021).","journal-title":"PLoS ONE"},{"key":"28215_CR25","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1016\/j.ajpath.2015.08.017","volume":"185","author":"H Wang","year":"2015","unstructured":"Wang, H., Fotheringham, L., Wittchen, E. S. & Hartnett, M. E. Rap1 GTPase inhibits tumor necrosis factor-\u03b1-induced choroidal endothelial migration via NADPH oxidase- and NF-\u03baB-dependent activation of Rac1. Am. J. Pathol. 185, 3316\u20133325. https:\/\/doi.org\/10.1016\/j.ajpath.2015.08.017 (2015).","journal-title":"Am. J. Pathol."},{"key":"28215_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4161\/cc.27353","volume":"13","author":"H Wei","year":"2014","unstructured":"Wei, H., Mundade, R., Lange, K. C. & Lu, T. Protein arginine methylation of non-histone proteins and its role in diseases. Cell Cycle 13, 32\u201341. https:\/\/doi.org\/10.4161\/cc.27353 (2014).","journal-title":"Cell Cycle"},{"key":"28215_CR27","doi-asserted-by":"publisher","first-page":"39963","DOI":"10.18632\/oncotarget.18102","volume":"8","author":"L Prabhu","year":"2017","unstructured":"Prabhu, L. et al. Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers. Oncotarget 8, 39963\u201339977. https:\/\/doi.org\/10.18632\/oncotarget.18102 (2017).","journal-title":"Oncotarget"},{"key":"28215_CR28","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.18632\/aging.202407","volume":"13","author":"Y Yan","year":"2021","unstructured":"Yan, Y. et al. PRMT5 regulates colorectal cancer cell growth and EMT via EGFR\/Akt\/GSK3\u03b2 signaling cascades. Aging 13, 4468\u20134481. https:\/\/doi.org\/10.18632\/aging.202407 (2021).","journal-title":"Aging"},{"key":"28215_CR29","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1177\/0963689719885083","volume":"28","author":"Y Li","year":"2019","unstructured":"Li, Y., Yang, Y., Liu, X., Long, Y. & Zheng, Y. PRMT5 promotes human lung cancer cell apoptosis via Akt\/Gsk3\u03b2 signaling induced by resveratrol. Cell Transplant. 28, 1664\u20131673. https:\/\/doi.org\/10.1177\/0963689719885083 (2019).","journal-title":"Cell Transplant."},{"key":"28215_CR30","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/cam4.1360","volume":"7","author":"H Jiang","year":"2018","unstructured":"Jiang, H. et al. PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma. Cancer Med. 7, 869\u2013882. https:\/\/doi.org\/10.1002\/cam4.1360 (2018).","journal-title":"Cancer Med."},{"key":"28215_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12964-019-0344-4","volume":"17","author":"Y Qin","year":"2019","unstructured":"Qin, Y. et al. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7\/cMyc axis. Cell Commun. Signal. 17, 30. https:\/\/doi.org\/10.1186\/s12964-019-0344-4 (2019).","journal-title":"Cell Commun. Signal."},{"key":"28215_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bbrc.2018.11.036","volume":"507","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. The LINC01138 interacts with PRMT5 to promote SREBP1-mediated lipid desaturation and cell growth in clear cell renal cell carcinoma. Biochem. Biophys. Res. Commun. 507, 337\u2013342. https:\/\/doi.org\/10.1016\/j.bbrc.2018.11.036 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"28215_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11060-014-1419-0","volume":"118","author":"X Han","year":"2014","unstructured":"Han, X. et al. Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro. J. Neurooncol. 118, 61\u201372. https:\/\/doi.org\/10.1007\/s11060-014-1419-0 (2014).","journal-title":"J. Neurooncol."},{"key":"28215_CR34","doi-asserted-by":"publisher","first-page":"13516","DOI":"10.1073\/pnas.1311784110","volume":"110","author":"H Wei","year":"2013","unstructured":"Wei, H. et al. PRMT5 dimethylates R30 of the p65 subunit to activate NF-\u03baB. Proc. Natl. Acad. Sci. USA. 110, 13516\u201313521. https:\/\/doi.org\/10.1073\/pnas.1311784110 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"28215_CR35","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1039\/c7mb00391a","volume":"13","author":"L Prabhu","year":"2017","unstructured":"Prabhu, L. et al. Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases. Mol. Biosyst. 13, 2509\u20132520. https:\/\/doi.org\/10.1039\/c7mb00391a (2017).","journal-title":"Mol. Biosyst."},{"key":"28215_CR36","first-page":"515","volume":"21","author":"AA Wenzel","year":"2015","unstructured":"Wenzel, A. A., O\u2019Hare, M. N., Shadmand, M. & Corson, T. W. Optical coherence tomography enables imaging of tumor initiation in the TAg-RB mouse model of retinoblastoma. Mol. Vis. 21, 515\u2013522 (2015).","journal-title":"Mol. Vis."},{"key":"28215_CR37","doi-asserted-by":"publisher","first-page":"786","DOI":"10.15252\/emmm.201606561","volume":"9","author":"HD Basavarajappa","year":"2017","unstructured":"Basavarajappa, H. D. et al. Ferrochelatase is a therapeutic target for ocular neovascularization. EMBO Mol. Med. 9, 786\u2013801. https:\/\/doi.org\/10.15252\/emmm.201606561 (2017).","journal-title":"EMBO Mol. Med."},{"key":"28215_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1124\/jpet.118.248088","volume":"367","author":"SPB Sardar Pasha","year":"2018","unstructured":"Sardar Pasha, S. P. B. et al. Ref-1\/APE1 inhibition with novel small molecules blocks ocular neovascularization. J. Pharmacol. Exp. Ther. 367, 108\u2013118. https:\/\/doi.org\/10.1124\/jpet.118.248088 (2018).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"28215_CR39","doi-asserted-by":"publisher","first-page":"12419","DOI":"10.1096\/fj.202000964R","volume":"34","author":"SPS Pran Babu","year":"2020","unstructured":"Pran Babu, S. P. S., White, D. & Corson, T. W. Ferrochelatase regulates retinal neovascularization. FASEB J. 34, 12419\u201312435. https:\/\/doi.org\/10.1096\/fj.202000964R (2020).","journal-title":"FASEB J."},{"key":"28215_CR40","doi-asserted-by":"publisher","first-page":"24100","DOI":"10.1073\/pnas.1914143116","volume":"116","author":"AP Voigt","year":"2019","unstructured":"Voigt, A. P. et al. Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration. Proc. Natl. Acad. Sci. USA. 116, 24100. https:\/\/doi.org\/10.1073\/pnas.1914143116 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"28215_CR41","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1021\/acs.jmedchem.5b00449","volume":"58","author":"HD Basavarajappa","year":"2015","unstructured":"Basavarajappa, H. D. et al. Synthesis and biological evaluation of novel homoisoflavonoids for retinal neovascularization. J. Med. Chem. 58, 5015\u20135027. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00449 (2015).","journal-title":"J. Med. Chem."},{"key":"28215_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1073\/pnas.0912493107","volume":"107","author":"T Lu","year":"2010","unstructured":"Lu, T. et al. Regulation of NF-\u03baB by NSD1\/FBXL11-dependent reversible lysine methylation of p65. Proc. Natl. Acad. Sci. USA. 107, 46\u201351. https:\/\/doi.org\/10.1073\/pnas.0912493107 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"28215_CR43","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/onc.2016.287","volume":"36","author":"X Deng","year":"2017","unstructured":"Deng, X. et al. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth. Oncogene 36, 1223\u20131231. https:\/\/doi.org\/10.1038\/onc.2016.287 (2017).","journal-title":"Oncogene"},{"key":"28215_CR44","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1016\/j.celrep.2017.11.096","volume":"21","author":"K Chiang","year":"2017","unstructured":"Chiang, K. et al. PRMT5 is a critical regulator of breast cancer stem cell function via histone methylation and FOXP1 expression. Cell Rep. 21, 3498\u20133513. https:\/\/doi.org\/10.1016\/j.celrep.2017.11.096 (2017).","journal-title":"Cell Rep."},{"key":"28215_CR45","doi-asserted-by":"publisher","first-page":"9162","DOI":"10.7150\/thno.59605","volume":"11","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y. et al. PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression. Theranostics 11, 9162\u20139176. https:\/\/doi.org\/10.7150\/thno.59605 (2021).","journal-title":"Theranostics"},{"key":"28215_CR46","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/j.1349-7006.2012.02367.x","volume":"103","author":"T-YW Wei","year":"2012","unstructured":"Wei, T.-Y.W. et al. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins\/cyclin-dependent kinases and the phosphoinositide 3-kinase\/AKT signaling cascade. Cancer Sci. 103, 1640\u20131650. https:\/\/doi.org\/10.1111\/j.1349-7006.2012.02367.x (2012).","journal-title":"Cancer Sci."},{"key":"28215_CR47","first-page":"189","volume":"22","author":"H Wang","year":"2016","unstructured":"Wang, H. & Hartnett, M. E. Regulation of signaling events involved in the pathophysiology of neovascular AMD. Mol. Vis. 22, 189\u2013202 (2016).","journal-title":"Mol. Vis."},{"key":"28215_CR48","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1111\/j.1742-4658.2005.04979.x","volume":"272","author":"M Swiatkowska","year":"2005","unstructured":"Swiatkowska, M., Szemraj, J. & Cierniewski, C. S. Induction of PAI-1 expression by tumor necrosis factor \u03b1 in endothelial cells is mediated by its responsive element located in the 4G\/5G site. FEBS J. 272, 5821\u20135831. https:\/\/doi.org\/10.1111\/j.1742-4658.2005.04979.x (2005).","journal-title":"FEBS J."},{"key":"28215_CR49","doi-asserted-by":"publisher","first-page":"20221","DOI":"10.1074\/jbc.M313980200","volume":"279","author":"B Chandrasekar","year":"2004","unstructured":"Chandrasekar, B. et al. Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. J. Biol. Chem. 279, 20221\u201320233. https:\/\/doi.org\/10.1074\/jbc.M313980200 (2004).","journal-title":"J. Biol. Chem."},{"key":"28215_CR50","doi-asserted-by":"publisher","first-page":"4944","DOI":"10.1167\/iovs.13-13631","volume":"55","author":"C Cowan","year":"2014","unstructured":"Cowan, C. et al. MicroRNA-146 inhibits thrombin-induced NF-\u03baB activation and subsequent inflammatory responses in human retinal endothelial cells. Investig. Ophthalmol. Vis. Sci. 55, 4944\u20134951. https:\/\/doi.org\/10.1167\/iovs.13-13631 (2014).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"28215_CR51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/jcp.22708","volume":"227","author":"CN Nagineni","year":"2012","unstructured":"Nagineni, C. N., Kommineni, V. K., William, A., Detrick, B. & Hooks, J. J. Regulation of VEGF expression in human retinal cells by cytokines: Implications for the role of inflammation in age-related macular degeneration. J. Cell. Physiol. 227, 116\u2013126. https:\/\/doi.org\/10.1002\/jcp.22708 (2012).","journal-title":"J. Cell. Physiol."},{"key":"28215_CR52","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.redox.2014.01.023","volume":"2","author":"Y Li","year":"2014","unstructured":"Li, Y. et al. Inhibition of APE1\/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization. Redox Biol. 2, 485\u2013494. https:\/\/doi.org\/10.1016\/j.redox.2014.01.023 (2014).","journal-title":"Redox Biol."},{"key":"28215_CR53","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3892\/ijmm.2015.2202","volume":"36","author":"H Park","year":"2015","unstructured":"Park, H. et al. 3,3\u2019-Diindolylmethane inhibits VEGF expression through the HIF-1\u03b1 and NF-\u03baB pathways in human retinal pigment epithelial cells under chemical hypoxic conditions. Int. J. Mol. Med. 36, 301\u2013308. https:\/\/doi.org\/10.3892\/ijmm.2015.2202 (2015).","journal-title":"Int. J. Mol. Med."},{"key":"28215_CR54","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/nprot.2013.135","volume":"8","author":"V Lambert","year":"2013","unstructured":"Lambert, V. et al. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat. Protoc. 8, 2197\u20132211. https:\/\/doi.org\/10.1038\/nprot.2013.135 (2013).","journal-title":"Nat. Protoc."},{"key":"28215_CR55","doi-asserted-by":"publisher","DOI":"10.3791\/53502","author":"RS Shah","year":"2015","unstructured":"Shah, R. S., Soetikno, B. T., Lajko, M. & Fawzi, A. A. A mouse model for laser-induced choroidal neovascularization. J. Vis. Exp. https:\/\/doi.org\/10.3791\/53502 (2015).","journal-title":"J. Vis. Exp."},{"key":"28215_CR56","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1161\/ATVBAHA.107.151431","volume":"27","author":"K Izumi-Nagai","year":"2007","unstructured":"Izumi-Nagai, K. et al. Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb. Vasc. Biol. 27, 2555\u20132562. https:\/\/doi.org\/10.1161\/ATVBAHA.107.151431 (2007).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"28215_CR57","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1158\/0008-5472.CAN-15-1022","volume":"75","author":"T Lu","year":"2015","unstructured":"Lu, T. & Stark, G. R. NF-\u03baB: Regulation by methylation. Cancer Res. 75, 3692\u20133695. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1022 (2015).","journal-title":"Cancer Res."},{"key":"28215_CR58","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0014-4835(02)00332-9","volume":"76","author":"N Gupta","year":"2003","unstructured":"Gupta, N., Brown, K. E. & Milam, A. H. Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp. Eye Res. 76, 463\u2013471. https:\/\/doi.org\/10.1016\/S0014-4835(02)00332-9 (2003).","journal-title":"Exp. Eye Res."},{"key":"28215_CR59","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/path.4669","volume":"238","author":"S Zeng","year":"2016","unstructured":"Zeng, S. et al. Molecular response of chorioretinal endothelial cells to complement injury: Implications for macular degeneration. J. Pathol. 238, 446\u2013456. https:\/\/doi.org\/10.1002\/path.4669 (2016).","journal-title":"J. Pathol."},{"key":"28215_CR60","doi-asserted-by":"publisher","first-page":"100954","DOI":"10.1016\/j.preteyeres.2021.100954","volume":"84","author":"A Uemura","year":"2021","unstructured":"Uemura, A. et al. VEGFR1 signaling in retinal angiogenesis and microinflammation. Prog. Retin. Eye Res. 84, 100954. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100954 (2021).","journal-title":"Prog. Retin. Eye Res."},{"issue":"Pt 1","key":"28215_CR61","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","volume":"7","author":"J Stone","year":"1995","unstructured":"Stone, J. et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 7(Pt 1), 4738\u20134747. https:\/\/doi.org\/10.1523\/JNEUROSCI.15-07-04738.1995 (1995).","journal-title":"J. Neurosci."},{"key":"28215_CR62","doi-asserted-by":"publisher","first-page":"e11863","DOI":"10.1371\/journal.pone.0011863","volume":"5","author":"A Scott","year":"2010","unstructured":"Scott, A. et al. Astrocyte-derived vascular endothelial growth factor stabilizes vessels in the developing retinal vasculature. PLoS ONE 5, e11863. https:\/\/doi.org\/10.1371\/journal.pone.0011863 (2010).","journal-title":"PLoS ONE"},{"key":"28215_CR63","doi-asserted-by":"publisher","first-page":"107776","DOI":"10.1016\/j.celrep.2020.107776","volume":"31","author":"KA Guttenplan","year":"2020","unstructured":"Guttenplan, K. A. et al. Neurotoxic reactive astrocytes drive neuronal death after retinal injury. Cell Rep. 31, 107776. https:\/\/doi.org\/10.1016\/j.celrep.2020.107776 (2020).","journal-title":"Cell Rep."},{"key":"28215_CR64","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1242\/jcs.039933","volume":"122","author":"F Herrmann","year":"2009","unstructured":"Herrmann, F., Pably, P., Eckerich, C., Bedford, M. T. & Fackelmayer, F. O. Human protein arginine methyltransferases in vivo\u2014Distinct properties of eight canonical members of the PRMT family. J. Cell Sci. 122, 667\u2013677. https:\/\/doi.org\/10.1242\/jcs.039933 (2009).","journal-title":"J. Cell Sci."},{"key":"28215_CR65","first-page":"795","volume":"42","author":"NE Medeiros","year":"2001","unstructured":"Medeiros, N. E. & Curcio, C. A. Preservation of ganglion cell layer neurons in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 42, 795\u2013803 (2001).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"28215_CR66","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejphar.2016.03.066","volume":"787","author":"O Strau\u00df","year":"2016","unstructured":"Strau\u00df, O. Pharmacology of the retinal pigment epithelium, the interface between retina and body system. Eur. J. Pharmacol. 787, 84\u201393. https:\/\/doi.org\/10.1016\/j.ejphar.2016.03.066 (2016).","journal-title":"Eur. J. Pharmacol."},{"key":"28215_CR67","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3389\/fnins.2018.00834","volume":"12","author":"M Pietrucha-Dutczak","year":"2018","unstructured":"Pietrucha-Dutczak, M., Amadio, M., Govoni, S., Lewin-Kowalik, J. & Smedowski, A. The role of endogenous neuroprotective mechanisms in the prevention of retinal ganglion cells degeneration. Front. Neurosci. 12, 834. https:\/\/doi.org\/10.3389\/fnins.2018.00834 (2018).","journal-title":"Front. Neurosci."},{"key":"28215_CR68","first-page":"1236","volume":"37","author":"CA Curcio","year":"1996","unstructured":"Curcio, C. A., Medeiros, N. E. & Millican, C. L. Photoreceptor loss in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 37, 1236\u20131249 (1996).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"28215_CR69","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.mehy.2012.01.018","volume":"78","author":"MR Kozlowski","year":"2012","unstructured":"Kozlowski, M. R. RPE cell senescence: A key contributor to age-related macular degeneration. Med. Hypotheses 78, 505\u2013510. https:\/\/doi.org\/10.1016\/j.mehy.2012.01.018 (2012).","journal-title":"Med. Hypotheses"},{"key":"28215_CR70","doi-asserted-by":"publisher","first-page":"930671","DOI":"10.1155\/2014\/930671","volume":"2014","author":"M Nita","year":"2014","unstructured":"Nita, M., Grzybowski, A., Ascaso, F. J. & Huerva, V. Age-related macular degeneration in the aspect of chronic low-grade inflammation (pathophysiological parainflammation). Med. Inflamm. 2014, 930671. https:\/\/doi.org\/10.1155\/2014\/930671 (2014).","journal-title":"Med. Inflamm."},{"key":"28215_CR71","doi-asserted-by":"publisher","first-page":"108790","DOI":"10.1016\/j.biopha.2019.108790","volume":"114","author":"W Xiao","year":"2019","unstructured":"Xiao, W. et al. Role of protein arginine methyltransferase 5 in human cancers. Biomed. Pharmacother. 114, 108790. https:\/\/doi.org\/10.1016\/j.biopha.2019.108790 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"28215_CR72","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.1167\/iovs.09-3652","volume":"50","author":"SE Yanni","year":"2009","unstructured":"Yanni, S. E., Barnett, J. M., Clark, M. L. & Penn, J. S. The role of PGE2 receptor EP4 in pathologic ocular angiogenesis. Investig. Ophthalmol. Vis. Sci. 50, 5479\u20135486. https:\/\/doi.org\/10.1167\/iovs.09-3652 (2009).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"28215_CR73","doi-asserted-by":"publisher","first-page":"110999","DOI":"10.1016\/j.biopha.2020.110999","volume":"133","author":"H Han","year":"2021","unstructured":"Han, H. et al. Capilliposide B blocks VEGF-induced angiogenesis in vitro in primary human retinal microvascular endothelial cells. Biomed. Pharmacother. 133, 110999. https:\/\/doi.org\/10.1016\/j.biopha.2020.110999 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"28215_CR74","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0002-9440(10)61708-7","volume":"159","author":"F Chen","year":"2001","unstructured":"Chen, F., Castranova, V. & Shi, X. New insights into the role of nuclear factor-\u03baB in cell growth regulation. Am J. Pathol. 159, 387\u2013397. https:\/\/doi.org\/10.1016\/S0002-9440(10)61708-7 (2001).","journal-title":"Am J. Pathol."},{"key":"28215_CR75","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1128\/MCB.17.11.6526","volume":"17","author":"J Bash","year":"1997","unstructured":"Bash, J., Zong, W. X. & G\u00e9linas, C. c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1\/S-phase transition. Mol. Cell. Biol. 17, 6526\u20136536. https:\/\/doi.org\/10.1128\/MCB.17.11.6526 (1997).","journal-title":"Mol. Cell. Biol."},{"key":"28215_CR76","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1038\/sj.onc.1202657","volume":"18","author":"B Kaltschmidt","year":"1999","unstructured":"Kaltschmidt, B., Kaltschmidt, C., Hehner, S. P., Dr\u00f6ge, W. & Schmitz, M. L. Repression of NF-\u03baB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators. Oncogene 18, 3213\u20133225. https:\/\/doi.org\/10.1038\/sj.onc.1202657 (1999).","journal-title":"Oncogene"},{"key":"28215_CR77","first-page":"4446","volume":"59","author":"G Otsuka","year":"1999","unstructured":"Otsuka, G. et al. Inhibition of nuclear factor-\u03baB activation confers sensitivity to tumor necrosis factor-\u03b1 by impairment of cell cycle progression in human glioma cells. Cancer Res. 59, 4446 (1999).","journal-title":"Cancer Res."},{"key":"28215_CR78","doi-asserted-by":"publisher","first-page":"9429","DOI":"10.1021\/acs.jmedchem.8b00598","volume":"61","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Hu, W. & Yuan, Y. Protein arginine methyltransferase 5 (PRMT5) as an anticancer target and its inhibitor discovery. J. Med. Chem. 61, 9429\u20139441. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00598 (2018).","journal-title":"J. Med. Chem."},{"key":"28215_CR79","doi-asserted-by":"publisher","first-page":"199","DOI":"10.15698\/cst2020.08.228","volume":"4","author":"H Kim","year":"2020","unstructured":"Kim, H. & Ronai, Z. A. PRMT5 function and targeting in cancer. Cell Stress 4, 199\u2013215. https:\/\/doi.org\/10.15698\/cst2020.08.228 (2020).","journal-title":"Cell Stress"},{"key":"28215_CR80","doi-asserted-by":"publisher","first-page":"108286","DOI":"10.1016\/j.exer.2020.108286","volume":"202","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma. Exp. Eye Res. 202, 108286. https:\/\/doi.org\/10.1016\/j.exer.2020.108286 (2021).","journal-title":"Exp. Eye Res."},{"key":"28215_CR81","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.gendis.2019.06.002","volume":"6","author":"F Zhu","year":"2019","unstructured":"Zhu, F. & Rui, L. PRMT5 in gene regulation and hematologic malignancies. Genes Dis. 6, 247\u2013257. https:\/\/doi.org\/10.1016\/j.gendis.2019.06.002 (2019).","journal-title":"Genes Dis."},{"key":"28215_CR82","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/ncb2158","volume":"13","author":"J-M Hsu","year":"2011","unstructured":"Hsu, J.-M. et al. Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation. Nat. Cell Biol. 13, 174\u2013181. https:\/\/doi.org\/10.1038\/ncb2158 (2011).","journal-title":"Nat. Cell Biol."},{"key":"28215_CR83","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/ncb1802","volume":"10","author":"M Jansson","year":"2008","unstructured":"Jansson, M. et al. Arginine methylation regulates the p53 response. Nat. Cell Biol. 10, 1431\u20131439. https:\/\/doi.org\/10.1038\/ncb1802 (2008).","journal-title":"Nat. Cell Biol."},{"key":"28215_CR84","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1093\/nar\/gkq1264","volume":"39","author":"W He","year":"2011","unstructured":"He, W. et al. A role for the arginine methylation of Rad9 in checkpoint control and cellular sensitivity to DNA damage. Nucleic Acids Res. 39, 4719\u20134727. https:\/\/doi.org\/10.1093\/nar\/gkq1264 (2011).","journal-title":"Nucleic Acids Res."},{"key":"28215_CR85","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.ajpath.2021.01.016","volume":"191","author":"RP Homme","year":"2021","unstructured":"Homme, R. P., Sandhu, H. S., George, A. K., Tyagi, S. C. & Singh, M. Sustained inhibition of NF-\u03baB activity mitigates retinal vasculopathy in diabetes. Am. J. Pathol. 191, 947\u2013964. https:\/\/doi.org\/10.1016\/j.ajpath.2021.01.016 (2021).","journal-title":"Am. J. Pathol."},{"key":"28215_CR86","unstructured":"Lu, T. et al. PRMT5 inhibitors for ocular therapy. USA patent application 18\/061,219 (2022)."},{"key":"28215_CR87","unstructured":"Lu, T. & Prabhu, L. Small molecule protein arginine methyltransferase 5 (PRMT5) inhibitors and methods of treatment. USA patent 11,034,689 (2021)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28215-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28215-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28215-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T06:35:05Z","timestamp":1675146905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28215-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["28215"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-28215-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.30.486275","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]},"assertion":[{"value":"15 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.Mu., M.M., K.S., A.Mo., M.S., T.L., and T.W.C. are named inventors on U.S. Patent Application Number: 18\/061,219 related to this work<sup>86<\/sup>. PR5-LL-CM01 is protected by US Patent Award to T.L. and L.P.<sup>87<\/sup>. T.L. is the founder of EQon Pharmaceuticals, LLC, a company that owns the licensed patent rights for PR5-LL-CM01 from Indiana University. All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1747"}}